Stop CVS Caremarks Zepbound Ban Restore Coverage of the Superior Obesity Medication The Issue To: CVS Caremark Leadership We, the undersigned healthcare providers, patients, and concerned citizens, urgently petition CVS Caremark to reverse its decision to remove Zepbound (tirzepatide) from its standard commercial formularies, effective July 1, 2025
it is important to stay well hydrated and drink plenty of fluids while on this medication
Cold sensitivity on tirzepatide relates to reduced caloric intake and changes in thermogenesis
Research does show that weight regain is common when GLP-1 medications are discontinued without ongoing support, which is why PEAK's approach emphasizes building habits alongside medication
As the active ingredient in Ozempic and Wegovy , it works by targeting the brains appetite-control center , regulating blood sugar and insulin , and slowing digestion to naturally reduce hunger and food intake
Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, van der Velden WJ, Stutsman C, Cardona GR, et al